Dermata Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DRMA | ACR.AX | LEXX | LSTA | THAT.L | SBTX.L | |
|---|---|---|---|---|---|---|
| Market cap | 4.24M | 6.12M | 8.57M | 11.45M | 9.78M | 12.05M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.2 | — | -10.4 | -0.9 | — | 24.6 |
| Price/book | 1.0 | 3.3 | 1.4 | 1.2 | 2.8 | 1.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −73.22% | −33.33% | −75.12% | −53.42% | −4.17% | −70.00% |
| Today | +0.72% | 0.00% | +0.99% | −2.75% | −4.17% | −11.43% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All DRMA news ›Dermata Therapeutics, Inc. (DRMA) Starts Acne Trial, Targets H1 2027 Launch
TradingView Dermata Therapeutics, Inc. (DRMA) Starts Acne Trial, Targets H1 2027 Launch Dermata Therapeutics enrolled the first participant in an open-label trial of its once-weekly Tome Clearing Treatment for acne, aiming
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
- Tome Clearing Treatment is Dermata's second once-weekly skincare product under its Tome brand - - Tome Clearing Treatment includes a salicylic acid wipe with Dermata's Bioneedle™ mask and is expected to launch in H1 2027 for…
Dermata Therapeutics registers up to 6.92M resale shares
Dermata receives no proceeds from resales, while cash warrant exercises would provide proceeds for working capital and general corporate purposes. The auditor’s report on the incorporated financial statements includes an explanatory…
Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic Study
Dermata Therapeutics (NASDAQ:DRMA) jumps over 44% after positive topline results from a cosmetic study of its once-weekly Tome Foundational Treatment. Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive…
More from 1 other outlet
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments - - Over 71% of study participants were graded as having overall improvements in their skin after only one…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net2
- tradingview.com2
- investorideas.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.